Long-Term Safety, Tolerability, and Efficacy of Vismodegib in Two Patients With Metastatic Basal Cell Carcinoma and Basal Cell Nevus Syndrome. Dermatol Reports 2011, 3 (3), e55. https://doi.org/10.4081/dr.2011.e55.